期刊文献+

孟鲁司特钠佐治毛细支气管炎疗效观察 被引量:5

Efficacy observation of montelukast on the assistance treatment of capillarity bronchitis
下载PDF
导出
摘要 目的:观察孟鲁司特钠佐治毛细支气管炎的疗效。方法:将98例毛细支气管炎患儿随机分为对照组和治疗组。两组均给予抗病毒平喘雾化吸入综合治疗,治疗组加用孟鲁司特钠口服治疗。观察两组疗效及临床症状、体征持续时间。结果:治疗72h后治疗组显效率和总有效率分别为52.1%和93.8%,对照组分别为18.0%和68.0%,两组差异有统计学意义(P<0.01);治疗组喘憋、肺部哮鸣音的消失时间、平均住院时间都明显短于对照组(P<0.01)。结论:孟鲁司特钠佐治毛细支气管炎具有协同作用,可缓解临床症状,缩短病程,是佐治毛细支气管炎的有效药物。 Objective: To observe the effect of montelukast on the assistance treatment of capillarity bronchitis. Methods: 98 cases capillarity bronchitis children were divided into the treatment group and the control group. Two groups were given the anti-virus to breathe heavilyevenly the atomization inspiration complex therapy, the treatment group added. montelukast. Observed two groups of curative effects and the clinical symptoms, the symptom durationgs. Results: Treated 72 hours later, obvious efficiency and total effectiveness respectively the treatment group were 52.1% and 93.8%, the control group were 18.0% and 68.0%, the difference was significant (P0.01); the treatment group breathes heavily suppresses, the lungs heavy breathing calls the sound obviously the evanishment time, the average in hospital time all were shorter than the control group (P0.01). Conclusion: The assistance treatment of montelukast on capillarity bronchitis has the synergism, may alleviate the clinical symptoms, reduce the course.
出处 《中国当代医药》 2011年第22期59-60,共2页 China Modern Medicine
关键词 孟鲁司特钠 佐治 毛细支气管炎 疗效观察 Montelukast Assistance treatment Capillarity bronchitis Efficacy observation
  • 相关文献

参考文献6

二级参考文献50

共引文献54

同被引文献50

  • 1钱红萍.孟鲁司特钠治疗毛细支气管炎的临床疗效观察[J].浙江中医药大学学报,2010,34(6):888-889. 被引量:5
  • 2Wei Huang,Shu-Man Jiang,Lin Jia,Le-Qing You,Yao-Xing Huang,Yan-Mei Gong,Gui-Qin Wang.Effect of amitriptyline on gastrointestinal function and brain-gut peptides: A double-blind trial[J].World Journal of Gastroenterology,2013,19(26):4214-4220. 被引量:33
  • 3王素梅,潘同国,刘萍,王欣玲.孟鲁司特对呼吸道合胞病毒毛细支气管炎患儿尿白三烯E_4的影响[J].湖北医药学院学报,2011,30(5):514-516. 被引量:4
  • 4胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 5Bonville CA, Rosenberg HF, Domachowske JB. Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis [J]. Antiviral Res, 2006, 69(2): 53-59.
  • 6Lee FE, Walsh EE, Falsey AR, et al. Human infant respiratory syncytial virus (RSV) -specific type 1 and 2 cytokine responses ex vivo during primary RSV infection [ J]. J Infect Dis, 2007, 195 (12) : 1779-1788.
  • 7Lichtenstein GR,Bengtsson B, Haten-White L,et al. Oral budesonide for maintenance of remission of Crohhn's dis- ease:pooled safety analysis [J]. Alimentary Pharmacology and Therapeutics, 2009,29 (6) :643-653.
  • 8Szefler SJ,Carlsson LG,Uryniak T, et al. Budesonide inhala- tion suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma [J]. J Allergy Clin Immunol Praet, 2013,1 ( 1 ) : 58-64.
  • 9hazawa T, Adachi Y, Ito Y, et al. Aerosol characteristics of admixture of budesonide inhalation suspension with a be- ta2-agonist procaterol [J]. Allergol Int, 2013,62 ( 1 ) : 131 - 135.
  • 10Camargo CA Jr,Ramachandran S,Ryskina KL,et al. Asso- ciation between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Med- icaid plan [J]. Am J Health Syst Pharm,2007,64(10) : 1054- 1061.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部